{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T20:02:13Z","timestamp":1776715333372,"version":"3.51.2"},"reference-count":13,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.antiviral.2010.11.008","type":"journal-article","created":{"date-parts":[[2010,11,20]],"date-time":"2010-11-20T09:24:12Z","timestamp":1290245052000},"page":"71-74","source":"Crossref","is-referenced-by-count":46,"title":["Viral entry inhibitors block dengue antibody-dependent enhancement in vitro"],"prefix":"10.1016","volume":"89","author":[{"given":"Cindo O.","family":"Nicholson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua M.","family":"Costin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawne K.","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekachai","family":"Jenwitheesuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ram","family":"Samudrala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Isern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott F.","family":"Michael","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2010.11.008_bib0005","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1128\/JVI.02484-07","article-title":"Role of dendritic cells in antibody-dependent enhancement of dengue virus infection","volume":"82","author":"Boonak","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2010.11.008_bib0010","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jviromet.2005.05.006","article-title":"Dengue typing assay based on real-time PCR using SYBR Green I","volume":"129","author":"Chutinimitkul","year":"2005","journal-title":"J. Virol. Methods"},{"issue":"6","key":"10.1016\/j.antiviral.2010.11.008_bib0015","doi-asserted-by":"crossref","first-page":"e721","DOI":"10.1371\/journal.pntd.0000721","article-title":"Structural optimization and de novo design of dengue virus entry inhibitory peptides","volume":"4","author":"Costin","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.antiviral.2010.11.008_bib0020","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1126\/science.3277268","article-title":"Pathogenesis of dengue: challenges to molecular biology","volume":"239","author":"Halstead","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2010.11.008_bib0025","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1084\/jem.146.1.201","article-title":"Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody","volume":"146","author":"Halstead","year":"1977","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2010.11.008_bib0030","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1743-422X-2-49","article-title":"Peptide inhibitors of dengue virus and West Nile virus infectivity","volume":"2","author":"Hrobowski","year":"2005","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2010.11.008_bib0035","doi-asserted-by":"crossref","first-page":"411","DOI":"10.4269\/ajtmh.1988.38.411","article-title":"Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants","volume":"38","author":"Kliks","year":"1988","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2010.11.008_bib0040","doi-asserted-by":"crossref","first-page":"444","DOI":"10.4269\/ajtmh.1989.40.444","article-title":"Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever","volume":"40","author":"Kliks","year":"1989","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2010.11.008_bib0045","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.4049\/jimmunol.144.8.3183","article-title":"Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection","volume":"144","author":"Littaua","year":"1990","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2010.11.008_bib0050","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1743-422X-7-28","article-title":"Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient","volume":"7","author":"Schieffelin","year":"2010","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2010.11.008_bib0055","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1371\/journal.ppat.1000851","article-title":"Peptide inhibitors of dengue virus entry target a late stage fusion intermediate","volume":"6","author":"Schmidt","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2010.11.008_bib0060","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1086\/315215","article-title":"Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity","volume":"181","author":"Vaughn","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2010.11.008_bib0065","unstructured":"World Health Organization, 2009. Fact sheet no. 117. Available from: www.who.int\/mediacentre\/factsheets\/fs117\/en\/ (accessed 03.06.10)."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354210008107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354210008107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T07:26:51Z","timestamp":1685863611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354210008107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0166354210008107"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2010.11.008","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}